Wednesday, October 31, 2012


The First Wealth is Health (R.W.Emerson)

StemLife has a proven track record of success in releasing stem cells for treatments, especially in young patients with leukaemia, thalassaemia and cerebral palsy, and adults with knee injuries, chronic wounds, heart disease and more.
StemLife is a FULLY LICENSED cord blood and peripheral blood stem cell banking facility, under the PHFS Act 1998, Ministry of Health Malaysia.
More than 40,000 clients have already stored their stem cells with StemLife, what are you waiting for? Store today!

Stemlife has announced that it has fallen out of favor to acquire Tonik Asia Group because it cannot come to terms with the vendor on certain matters after a due diligence is carried out. The bonus issue of 1 for 2 is on track. It will be interesting to watch how investors react to the news.

For more information about Stemlife, click here: